Identification of novel, potent and selective GCN2 inhibitors as first-in-class anti-tumor agents
收藏Protein Data Bank Japan2024-03-13 更新2026-03-21 收录
下载链接：
https://pdbj.org/mine/summary/6n3o
下载链接
链接失效反馈官方服务：
资源简介：
Identification of novel, potent and selective GCN2 inhibitors as first-in-class anti-tumor agents Descriptor: N-{3-[(2-aminopyrimidin-5-yl)ethynyl]-2,4-difluorophenyl}-5-chloro-2-methoxypyridine-3-sulfonamide, eIF-2-alpha kinase GCN2 Authors: Hoffman, I.D, Fujimoto, J, Kurasawa, O, Takagi, T, Klein, M.G, Kefala, G, Ding, S.C, Cary, D.R, Mizojiri, R. Deposit date: 2018-11-15 Release date: 2019-10-09 Last modified: 2024-03-13 Method: X-RAY DIFFRACTION (2.4 Å) Cite: Identification of Novel, Potent, and Orally Available GCN2 Inhibitors with Type I Half Binding Mode. Acs Med.Chem.Lett., 10, 2019
创建时间：
2018-11-15
